{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > DNA Damage & DNA Repai > BRD3308CAS：1550053-02-5
Molecular Formula：C15H14FN3O2
Molecular Weight：287.29
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：Off-white to light yellow Solid
Qty：
Size：
| CAS | 1550053-02-5 |
| Name | BRD3308 |
| Molecular Formula | C15H14FN3O2 |
| Molecular Weight | 287.29 |
| Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | Off-white to light yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD30187588 |
| SMILES | CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)F)N |
| InChIKey | RRJDFENBXIEAPD-UHFFFOYSA-N |
| InChI | InChI=1S/C15H14FN3O2/c1-9(20)18-12-5-2-10(3-6-12)15(21)19-14-7-4-11(16)8-13(14) 17/h2-8H，17H2，1H3，(H，18，20)(H，19，21) |
| PubChem CID | 72734382 |
| Target Point | HDAC3;HIV-1 |
| Passage | DNA Damage/DNA Repair;Epigenetics;NF-κB;Anti-infection |
| Background | BRD3308 is a highly selective HDAC3 inhibitor. BRD3308 also activates HIV-1 transcription and disrupts HIV-1 latency. |
| Unit | Bottle |
| Specification | 1mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
